BRAIx Predicts Short-Term Breast Cancer Risk

An Australian study published in The Lancet Digital Health today finds that an AI tool, BRAIx, predicted short-term breast cancer risk among women with clear mammograms. Across 95,823 Australian patients (1.1% developed cancer within four years) and 4,430 Swedish patients (6.9% within two years), BRAIx identified higher risk one to two years after clear screens, with lower accuracy at three to four years. The tool is now being trialled in Victoria.
Key Points
- 1Demonstrates BRAIx predicts one-to-two-year post-clear-screen cancer risk in an Australian cohort.
- 2Highlights potential to detect interval cancers missed by biennial mammography, improving early detection rates.
- 3Suggests using BRAIx to triage 6–7% high-risk women for MRI or contrast-enhanced mammography.
Scoring Rationale
Peer-reviewed Lancet study shows actionable screening improvements; limited by modest novelty and reduced accuracy beyond two years.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems

